NO970805L - Anvendelse av smaklös, hydrolysert kollagen og middel inneholdende samme - Google Patents

Anvendelse av smaklös, hydrolysert kollagen og middel inneholdende samme

Info

Publication number: NO970805L
Authority: NO; Norway
Prior art keywords: pct; hydrolyzed collagen; tasteless; same; agent containing
Prior art date: 1994-08-23

Application number

NO970805A

Other languages

English (en)

Other versions

NO970805D0 (no

NO318182B1 (no

Inventor

Adam Milan

Bernd Eggersgluess

Klaus Brauemer

Reinhard Schrieber

Original Assignee

Dgf Stoess Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-23

Filing date

1997-02-21

Publication date

1997-02-21

1997-02-21 Application filed by Dgf Stoess Ag filed Critical Dgf Stoess Ag

1997-02-21 Publication of NO970805D0 publication Critical patent/NO970805D0/no

1997-02-21 Publication of NO970805L publication Critical patent/NO970805L/no

2005-02-14 Publication of NO318182B1 publication Critical patent/NO318182B1/no

Links

102000008186 Collagen Human genes 0.000 title abstract 2
108010035532 Collagen Proteins 0.000 title abstract 2
229920001436 collagen Polymers 0.000 title abstract 2
230000009967 tasteless effect Effects 0.000 title 1
108010010803 Gelatin Proteins 0.000 abstract 2
208000001132 Osteoporosis Diseases 0.000 abstract 2
RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 2
239000003795 chemical substances by application Substances 0.000 abstract 2
229920000159 gelatin Polymers 0.000 abstract 2
239000008273 gelatin Substances 0.000 abstract 2
235000019322 gelatine Nutrition 0.000 abstract 2
235000011852 gelatine desserts Nutrition 0.000 abstract 2
102000055006 Calcitonin Human genes 0.000 abstract 1
108060001064 Calcitonin Proteins 0.000 abstract 1
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 1
229960004015 calcitonin Drugs 0.000 abstract 1
159000000007 calcium salts Chemical class 0.000 abstract 1
210000002808 connective tissue Anatomy 0.000 abstract 1
229960003387 progesterone Drugs 0.000 abstract 1
239000000186 progesterone Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/84—Bones; tendons; teeth; cartilage

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Organic Chemistry (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Orthopedic Medicine & Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Seasonings (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Cosmetics (AREA)

NO19970805A 1994-08-23 1997-02-21 Anvendelse av smaksnoytralt, enzymatisk, hydrolysert kollagen fra dyrisk hud og middel inneholdende samme. NO318182B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4429842		1994-08-23
PCT/EP1995/003304 WO1996005851A1 (de)	1994-08-23	1995-08-19	Verwendung von geschmacksneutralem, hydrolysiertem kollagen und mittel enthaltend dasselbe

Publications (3)

Publication Number	Publication Date
NO970805D0 NO970805D0 (no)	1997-02-21
NO970805L true NO970805L (no)	1997-02-21
NO318182B1 NO318182B1 (no)	2005-02-14

Family

ID=6526329

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19970805A NO318182B1 (no)	1994-08-23	1997-02-21	Anvendelse av smaksnoytralt, enzymatisk, hydrolysert kollagen fra dyrisk hud og middel inneholdende samme.

Country Status (12)

Country	Link
US (1)	US5948766A (no)
EP (1)	EP0777491B1 (no)
JP (1)	JPH10504555A (no)
AT (1)	ATE282423T1 (no)
AU (1)	AU703137B2 (no)
CA (1)	CA2198099C (no)
DE (1)	DE59510968D1 (no)
ES (1)	ES2233947T3 (no)
FI (1)	FI118513B (no)
NO (1)	NO318182B1 (no)
PT (1)	PT777491E (no)
WO (1)	WO1996005851A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4609807B2 (ja) *	1996-03-28	2011-01-12	雪印乳業株式会社	骨強化用医薬、飲食品及び飼料
JPH1112192A (ja) *	1997-06-18	1999-01-19	Zenyaku Kogyo Kk	骨粗鬆症予防・治療剤
US7691829B2 (en) *	1998-03-24	2010-04-06	Petito George D	Composition and method for healing tissues
US20050208114A1 (en) *	1998-03-24	2005-09-22	Petito George D	Composition and method for healing tissues
JP2009148275A (ja) *	2000-08-30	2009-07-09	Morisuke Yokoyama	特定保健用食品
ITRM20010380A1 (it) *	2001-07-02	2003-01-02	Bioprogress Spa	Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
JP4766818B2 (ja) *	2002-07-24	2011-09-07	隆文小濱	妊娠時に特異的な腰痛、股関節痛及び鼠径部痛の改善・治療剤
DE10339180A1 (de) *	2003-08-21	2005-03-24	Deutsche Gelatine-Fabriken Stoess Ag	Kollagenhydrolysat
AU2005330856B2 (en) *	2005-04-13	2011-05-19	Megmilk Snow Brand Co., Ltd.	Nutrient composition
US8187639B2 (en)	2005-09-27	2012-05-29	Tissue Tech, Inc.	Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US8182841B2 (en)	2005-09-27	2012-05-22	Tissue Tech, Inc.	Amniotic membrane preparations and purified compositions and anti-inflammation methods
ES2288791B1 (es) *	2006-02-10	2008-12-01	Masterfarm, S.L.	Procedimiento de obtencion de un hidrolizado de colageno. hidrolizado enzimatico de colageno obtenible por el procedimiento y usos del mismo.
ES2298071B1 (es) *	2006-10-25	2009-07-28	Masterfarm,S.L.	Hidrolizado enzimatico de colageno y procedimiento de obtencion.
US20100113368A1 (en) *	2007-03-21	2010-05-06	Luppo Edens	Cholesterol lowering protein hydrolysates
JP2008231065A (ja) *	2007-03-23	2008-10-02	Chisso Corp	骨代謝改善剤
US20110312928A1 (en) *	2010-06-18	2011-12-22	Lipocine Inc.	Progesterone Containing Oral Dosage Forms and Related Methods
US9375437B2 (en)	2010-06-18	2016-06-28	Lipocine Inc.	Progesterone containing oral dosage forms and kits
DE102011000997A1 (de)	2011-03-01	2012-09-06	Gelita Ag	Zusammensetzung für Ernährungszwecke
WO2012149486A1 (en)	2011-04-28	2012-11-01	Tissuetech, Inc.	Methods of modulating bone remodeling
US8951996B2 (en)	2011-07-28	2015-02-10	Lipocine Inc.	17-hydroxyprogesterone ester-containing oral compositions and related methods
DE102012110612A1 (de)	2012-11-06	2014-05-08	Gelita Ag	Kollagenhydrolysat und dessen Verwendung
US10226422B2 (en)	2013-01-23	2019-03-12	Bottled Science Limited	Skin enhancing beverage composition
WO2016210003A2 (en)	2015-06-22	2016-12-29	Lipocine Inc.	17-hydroxyprogesterone ester-containing oral compositions and related methods
TW201733600A (zh)	2016-01-29	2017-10-01	帝聖工業公司	胎兒扶持組織物及使用方法
EP3595695A1 (en) *	2017-03-15	2020-01-22	Rousselot B.V.	Compositions of hydrolyzed collagen peptides and commensal microorganisms and methods thereof
DE102019202606A1 (de)	2018-11-06	2020-05-07	Gelita Ag	Rekombinante Herstellung eines Kollagenpeptidpräparates und dessen Verwendung
DE102020126594A1 (de) *	2020-10-09	2022-04-14	Gelita Ag	Kollagenhydrolysat als Wirkstoff zum Verzögern der Alterung
DE102021119031B4 (de)	2021-07-22	2024-08-08	Manfred Lotz	Behandlung von Polymyalgia Rheumatica

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1227534A (no) *	1967-08-31	1971-04-07
CA1302880C (en) *	1986-07-25	1992-06-09	Peter Koepff	Agents for the treatment of arthroses
DE3626414C2 (de) *	1986-08-05	1994-11-10	Robapharm Ag	Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
CN1045719C (zh) *	1993-04-10	1999-10-20	北京市西城区华新生化技术研究所	口服接骨和治骨质疏松液
US5641747A (en) *	1994-07-25	1997-06-24	Temple University-Of The Commonwealth System Of Higher Education	Treatment of osteopetrotic diseases

1995
- 1995-08-19 US US08/793,252 patent/US5948766A/en not_active Expired - Lifetime
- 1995-08-19 PT PT95929893T patent/PT777491E/pt unknown
- 1995-08-19 EP EP95929893A patent/EP0777491B1/de not_active Expired - Lifetime
- 1995-08-19 ES ES95929893T patent/ES2233947T3/es not_active Expired - Lifetime
- 1995-08-19 AU AU33470/95A patent/AU703137B2/en not_active Ceased
- 1995-08-19 AT AT95929893T patent/ATE282423T1/de active
- 1995-08-19 DE DE59510968T patent/DE59510968D1/de not_active Expired - Lifetime
- 1995-08-19 WO PCT/EP1995/003304 patent/WO1996005851A1/de not_active Ceased
- 1995-08-19 CA CA002198099A patent/CA2198099C/en not_active Expired - Fee Related
- 1995-08-19 JP JP8507790A patent/JPH10504555A/ja active Pending
1997
- 1997-02-19 FI FI970703A patent/FI118513B/fi active IP Right Grant
- 1997-02-21 NO NO19970805A patent/NO318182B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE59510968D1 (de)	2004-12-23
ATE282423T1 (de)	2004-12-15
US5948766A (en)	1999-09-07
NO970805D0 (no)	1997-02-21
ES2233947T3 (es)	2005-06-16
EP0777491B1 (de)	2004-11-17
CA2198099A1 (en)	1996-02-29
CA2198099C (en)	2001-01-16
JPH10504555A (ja)	1998-05-06
WO1996005851A1 (de)	1996-02-29
AU3347095A (en)	1996-03-14
NO318182B1 (no)	2005-02-14
FI118513B (fi)	2007-12-14
AU703137B2 (en)	1999-03-18
FI970703L (fi)	1997-02-19
EP0777491A1 (de)	1997-06-11
PT777491E (pt)	2005-01-31
FI970703A0 (fi)	1997-02-19

Publication	Publication Date	Title
NO970805L (no)	1997-02-21	Anvendelse av smaklös, hydrolysert kollagen og middel inneholdende samme
NO2014010I1 (no)	2014-06-02	Radium 223 salt slik som Radium 223 diklorid
IS1724B (is)	1999-09-06	Aðferð við meðhöndlun á ígræðlingi úr málmi fyrirskurðaðgerð
NO962162D0 (no)	1996-05-28	Dipeptider som bevirker frigjöring av veksthormon
DE69507029D1 (de)	1999-02-11	Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten
ATE235253T1 (de)	2003-04-15	Prophylaktische immunisierende milchpräparation gegen otitis
PT758241E (pt)	2002-10-31	Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
FI970101A0 (fi)	1997-01-10	Uusi farmaseuttinen valmiste kivun hallintaan
ATE217197T1 (de)	2002-05-15	Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa
DE69401577D1 (de)	1997-03-06	Verabreichung von lamotrigin zur behandlung von neuro-aids
BR9509975A (pt)	1998-06-09	Formulação farmacêutica
TR199701121T1 (xx)	1998-03-21	Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.
NO971182D0 (no)	1997-03-14	Anvendelse av 2,4-diaminopyrimidin-3-oksyd eller et salt derav for behandling av maturasjons- og struktureringsforstyrrelser av kollagen
DE69634487D1 (de)	2005-04-21	Verfahren zur behandlung navikularer krankheiten bei pferden
NO179009C (no)	1996-07-17	Analogifremgangsmåte for fremstilling av salter av L-alfa-glyserofosforyl-D-myo-inositol
DK0804152T3 (da)	2000-02-14	Lactulose-pastiller
AU7710096A (en)	1997-06-19	A composition for odontostomatological use in cleaning and disinfecting the root canals and viable dentine
DK0569411T3 (da)	1995-08-28	Acylaminoalkylidenhydroxybiphosphonsyrer anvendelige til behandling af osteoartikulære sygdomme
DE69626276D1 (de)	2003-03-27	Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen
FR2613621B1 (fr)	1990-06-29	Butyl hydroxyanisoles pour utilisation dans le traitement prophylactique des maladies a retro-virus comme agents modificateurs de l'infectivite des retro-virus et produits anti-infectants
EA199800953A1 (ru)	1999-04-29	Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения
DE69606627D1 (de)	2000-03-16	Pharmazeutische zusammensetzungen zur polarisationsregulierung der einheitlichen glatten muskeln
FR2700116B1 (fr)	1995-02-03	Application d'anticonvulsivants comme radioprotecteurs.
DE69832796D1 (de)	2006-01-19	Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen

Legal Events

Date	Code	Title	Description
2011-04-04	MM1K	Lapsed by not paying the annual fees